Renaissance BioScience has received a boost to its ongoing research and development through the advancement of its proprietary, non-GMO yeast strain development platform.
The company will receive a multi-year, non-repayable contribution of up to Cdn$500,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).
As part of the company’s ongoing focus to develop innovative non-GMO yeast technology, Renaissance BioScience is engaged in the research and development of novel yeast strains for commercialization.
It is also involved in the discovery and utilization of advanced technology capable of improving the company’s proprietary strain development platform.
Dr. Matthew Dahabieh, chief science officer at Renaissance BioScience, explained: “We are pleased to receive funding from IRAP in support of furthering our next-generation non-GMO yeast development platform.
“The assistance offered by IRAP is an important catalyst for us to enhance our strain development capabilities and will enable us to take the next step in offering innovative next-generation yeast technology to our customers. We thank the Government of Canada and IRAP and for their support.”